- Home
- CIGI vs RVMD Comparison
CIGI vs RVMD Comparison
Compare CIGI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIGI | RVMD |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 15.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CIGI | RVMD |
|---|---|---|
| Price | $150.32 | $81.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 17 |
| Target Price | ★ $175.00 | $77.47 |
| AVG Volume (30 Days) | 112.5K | ★ 2.4M |
| Earning Date | 02-05-2026 | 11-05-2025 |
| Dividend Yield | ★ 0.20% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $5,453,534,000.00 | N/A |
| Revenue This Year | $17.67 | N/A |
| Revenue Next Year | $7.35 | $714.50 |
| P/E Ratio | $65.37 | ★ N/A |
| Revenue Growth | ★ 19.71 | N/A |
| 52 Week Low | $100.86 | $29.17 |
| 52 Week High | $171.51 | $81.97 |
Technical Indicators
Market Signals| Indicator | CIGI | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 70.71 |
| Support Level | $142.23 | $74.20 |
| Resistance Level | $147.75 | $80.44 |
| Average True Range (ATR) | 3.22 | 2.53 |
| MACD | 1.02 | -0.48 |
| Stochastic Oscillator | 92.58 | 91.30 |
Price Performance
Historical ComparisonAbout CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are; Real Estate Services, Engineering, Investment Management, and Corporate. Maximum revenue for the company is generated from its Real Estate Services segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, property sales brokerage, and lease brokerage services, among others. Geographically, the company generates maximum revenue from the United States and the rest from Canada, Australia, the United Kingdom, Poland, China, India, and other regions.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.